Catabasis Pharma (CATB) Announces Positive MoveDMD Trial Results at American Academy of Neurology Meeting
Tweet Send to a Friend
atabasis Pharmaceuticals, Inc. (NASDAQ: CATB) announced additional favorable results across multiple functional assessments in the MoveDMD trial at the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
